[Scleroderma, an ageing process? I. Clinical and immunological aspects (author's transl)]

Area of Science:

• Immunology
• Rheumatology
• Pathology

Context:

• Scleroderma is a complex disease affecting connective tissue and the vascular system.
• It is characterized by alterations in collagen, particularly a decrease in embryonic collagen type III.
• Autoimmune phenomena, both humoral and cellular, are key features.

Purpose:

• To investigate the autoimmune aspects of scleroderma.
• To explore the potential role of premature aging in immunocytes and fibroblasts in scleroderma pathogenesis.
• To identify specific cellular immune responses in patients.

Summary:

• The study found antinuclear antibodies in over 70% of scleroderma patients.
• Leukocytemigration inhibition tests revealed cellular immune responses to RNA, collagen, and muscle.
• A link between aging and immune defense/repair mechanisms in immunocytes and fibroblasts was noted.

Impact:

• Understanding the role of premature aging in scleroderma could elucidate its largely unknown etiopathogenesis.
• Identifying specific autoimmune markers aids in disease characterization.
• This research may lead to novel therapeutic strategies targeting immune dysregulation and cellular aging.